Home 
Blogs Chief Editor Rob Wright
Blogs Chief Editor Rob Wright
Monday, 11 March 2013 00:00
How Important Is Medical Innovation To The U.S. Economy?
Written by Rob Wright
Last week I received a phone call from Paul Foy, business writer for the Associated Press (AP). Foy was conducting research for an article and was looking for insight on the size of the pharmaceutical industry. My initial response was to ask for clarification on what he meant by size. He informed me he was…
Thursday, 28 February 2013 00:00
Is BIO International Too Big To Effectively Network?
Written by Rob Wright
When I reflect back on some of the recent articles written for Life Science Leader magazine, it is interesting to note how many of them began with a simple discussion while attending an event. BIO International is one event that has been very fruitful for Life Science Leader — providing us with opportunities to network…
Wednesday, 20 February 2013 05:00
Chance Meeting Leads To A Motivational Moment
Written by Rob Wright
A funny thing happened on a plane to Boston last year. The experience reminded me of the importance of being open to connecting. I had just finished climbing into the middle seat between two strangers, and stuffed my bag under the seat in front of me. The person occupying the window seat looked over at…
Friday, 15 February 2013 05:00
How To Make The Most Of Attending Bio International 2013
Written by Rob Wright
In the January 2013 issue of Life Science Leader magazine, I listed My Top 10 Life Science Shows for 2013. One of those shows is BIO International 2013, which is only 10 weeks away (April 22-25, in Chicago). This leaves you plenty of time to make the most of this show — if you start…
Tuesday, 05 February 2013 05:00
Super Bowl Ads Highlight Missed Opportunity For PhRMA
Written by Rob Wright
Like 108+ million other people, I watched the 2013 Super Bowl, which has grown into a spectacle of sport and marketing — broadcast live in more than 180 countries, in more than 30 different languages. Despite a 34-minute power outage which interrupted this year’s game, the 2013 Super Bowl was the 3rd most watched broadcast…
January 28th is a significant date, and not because in 1922 the American Football Association renamed itself the National Football League (NFL). No, it is something much more significant than the NFL, though it does involve the NFL. The 28th of January 2013 is known as Media Day — and signifies the start of the…
Insights From An OxyContin Security Expert Do you know who’s touching your stuff? This was the question posed by Charles Forsaith to an invite-only audience during a recent Marken-sponsored roundtable discussion. Forsaith, a 20- year law enforcement veteran and former U.S. military security operations director, functions as the supply chain security director for Purdue Pharma…
A little more than 20 years ago, 12 male volunteers were reporting the effects of a new potential angina drug to a Pfizer clinical research associate. One of the men reported an unusual finding – sustained and frequent erections. But this proved to break the ice as the others also were in agreement. The clinician…
Monday, 14 January 2013 05:00
Why J.P. Morgan Healthcare Conference Remains Relevant
Written by Rob Wright
Many of my colleagues wrote recaps of the 31st Annual J.P. Morgan (JPM) Healthcare Conference wondering if the event is still relevant — claiming that much of the deal making takes place away from the Westin St. Francis Hotel in San Francisco. Perhaps this is true. However, there is no doubt that the conference remains…
Monday, 07 January 2013 00:00
Is The U.S. Still The Biggest Pharma Game In Town?
Written by Rob Wright
I recently had a discussion with an EU-based pharma company executive. What was interesting was how this person consistently referred to the U.S. as North America and NAFTA. I struggled to keep from laughing out loud. Here’s why. Mexico’s legal pharmaceutical market is around $11 billion, and Canada’s is a bit over $20 billion. Not…
Editorial Board Blogs
-
World Food Prize Honors Ag Biotech Pioneers
World Food Prize Honors Ag Biotech Pioneers
A trio of scientists specializing in agricultural biotechnology will receive the 2013 World Food Prize, Secretary of State John Kerry announced today.
Mary-Dell Chilton, Robert T. Fraley and Marc Van Montagu, all pioneers in the science of agricultural biotechnology, have[…]
Source: BIOtechNow
-
Commercialization, Collaboration Mark Day Two at BIO’s World Congress
Commercialization, Collaboration Mark Day Two at BIO’s World Congress
Several companies made announcements yesterday during BIO’s 10th Annual World Congress on Industrial Biotech showcasing industry collaboration and commercial production. During a morning breakout session, Direct Conversion of Methane to Higher Value Products Using Biological Systems, Josh Silverman of Calysta[…]
Source: BIOtechNow
-
Drawing: A Life Lesson
Drawing: A Life Lesson
By John Baldoni, Chair, Leadership Development, N2growth
“John, do you understand what’s going on in this class?”
My college art instructor asked me that question nearly 40 years ago and I remember his words as if they were said yesterday. I[…]
Source: N2Growth Blog
-
5 Transitions Great Leaders Make That Average Leaders Don’t
5 Transitions Great Leaders Make That Average Leaders Don’t
By Mike Myatt, Chief Executive Officer, N2growth
The secret to leadership is there aren’t any real secrets. The best leaders have simply gone to school on improving their tradecraft. While the capabilities possessed by the best leaders might seem otherworldly to many,[…]
Source: N2Growth Blog
-
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs — How Valuable Is Their Advice?
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs — How Valuable Is Their Advice?
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new drug to treat cancer, Alzheimer’s[…]
Source: Drug Truths
-
NEJM Sheds Light On Payments To Doctors
NEJM Sheds Light On Payments To Doctors
It should come as no surprise that pharmaceutical companies pay doctors for a variety of reasons such as research, lecturing, and teaching. Such payments are justified as these physicians tend to be in demand as experts and their expertise is[…]
Source: Drug Truths
-
Careering around in Cheltenham!
Careering around in Cheltenham!
Careering around in Cheltenham! By Katrina Brockbank Last month I attended the Cheltenham Festivals “Careering Around” careers fair. Run by STEMNET (Science, Technology, Engineering and Mathematics network) the careers fair aimed to introduce young people to the professional opportunities that[…]
Source: Freeman Technology - Free Flow
-
The missing link?
The missing link?
The missing link? By Tim Freeman I recently attended the Arden House Conference (48th AAPS Annual Arden House Conference) which this year was focusing on advances in pharmaceutical material characterisation and their importance in the effective application of QbD. There[…]
Source: Freeman Technology - Free Flow
By A Web Design
